Request Trial
shutterstock_1386380144_ingus_kruklitis
Ingus Kruklitis / Shutterstock.com
4 June 2019

C5’s 18th International forum on Pharmaceutical Patent Term Extensions

Don’t miss this opportunity to join the European Commission, European Patent Office, German, Netherland, and Portuguese patent offices, and leading pharmaceutical in-house decision makers to tackle current pharma patent term extensions challenges in Europe and worldwide at C5’s 18th International forum on Pharmaceutical Patent Term Extensions in Munich, June 25 & 26.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Skinny labels, big stakes: SCOTUS lines up the case of the year
21 January 2026   The court’s review of a high-profile dispute could offer clarity on a grey area for pharma companies and generic drug makers, but also prompt fresh questions.
Asia
Chinese biotech strikes billion dollar deal in nextgen cancer race
20 January 2026   Magic Circle and major US firm among dealmakers who worked on the licensing agreement for a bispecific antibody candidate, marking another significant outbound licensing deal from China’s biopharma sector.
Americas
$5.4bn medtech leader fails to bury a rival's patent
19 January 2026   An Israeli medical device company’s lawsuit claims Edwards knowingly infringed its heart-valve patent, raising new risks as the giant pursues growth beyond its core market.


Editor's picks

Final call: Who are the world’s best in-house counsel?
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026

Editor's picks

Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025
Americas
US govt backs Hikma over ‘skinny label’ rules
9 December 2025
Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025

More features

Why the US is poised for a patent litigation surge in 2026
How AI will be shaped by legal and regulatory developments in 2026
Key EU and UK regulatory changes to watch for in 2026
UPC: A review of 2025 and what to expect in 2026
From Edwards to Insulet: Three key medical device cases of 2025
EU unveils sweeping pharma, biotech, and medical device reforms
Regeneron v Alvotech: The big impact
Beyond traditional IP: A comprehensive AI strategy for life sciences